Highlighting innovation

Cultivated or cultured meat is an exciting technology that provides an alternative to traditional farmed, animal meat. It has various advantages in environmental impact, animal welfare, and more. Meatly is a start-up producing cultivated, lab-grown meat and what sets them apart is that they specialise in producing pet food.

Sandeep Mangrati

October 30, 2024

Kadence Bio (formerly Kanna Health) is a clinical-stage drug development company pioneering new treatments for sexual health. Their lead asset, KH-001, is being developed as the first FDA-approved treatment for premature ejaculation. The company recently completed a Phase I clinical trial and is planning to initiate Phase II trials next year.

Laura Castillo De Franca

October 10, 2024

London, September 2024 - The Innovators Club, a network accelerator programme run by the Science Entrepreneur Club (SEC), has today announced its fifth cohort welcoming eight life science start-ups.

Matthew McCann

September 19, 2024

The SEC and SPARK have joined forces to launch a Midlands chapter of the SEC’s BioEntrepreneur Club, a collaborative and supportive peer-to-peer community exclusively for founders and C-suite in the life sciences.

Matthew McCann

September 10, 2024

A dementia diagnosis can leave people feeling adrift and alone. They’re often left with mounds of questions but very limited access to personalised information or specialists. We had the opportunity to speak to Anna Muñoz Farré, founder and CEO of Punto Health, about how they are starting a dementia care revolution. 

Megan Thomas

August 7, 2024

Over two decades ago, the World Health Organization (WHO) sounded the alarm on obesity, declaring it a global epidemic. Fast forward to 2013, and the WHO set an ambitious goal: halt the rise in obesity by 2030. But with just six years left, the numbers tell a different story...

George William Ssendagala

July 11, 2024

To find out investor’s thoughts on the biomaterials sector, we spoke to three members of our BioCapital Network; Sarah Jones - Principal at Zero Carbon Capital, Elisabetta Sakiotis - Analyst at Rockstart, and Josh Armistead-Wood - Senior Associate at Sustainable Ventures.

June 27, 2024

BoobyBiome, a start-up innovating the realm of infant health, is spearheading efforts to redefine neonatal care through a deep understanding of the gut microbiome. Founded by Lydia, Sioned, and Tara, they are dedicated to leveraging cutting-edge science to optimise infant health outcomes, particularly focusing on premature infants.

Joanna Myślińska

June 19, 2024

Whilst biomaterials are entering an exciting era within regenerative medicine, it has become clear the translation of principles across industries has opened the door for biomaterials to heal the planet. In this article we showcase creative interpretations of a biomaterial and their range of potential applications in a strive towards more sustainable products. 

June 12, 2024

Companies looking to get innovative biology to patients around the world need to be aware that it takes a 360-degree view of the intellectual property requirements, and in the case of CRISPR this landscape is becoming more and more convoluted, with companies scrambling to renegotiate licensing laws for GMOs to use in research and industry. Taken together, this points towards an opportunity for Forge Genetics to position themselves perfectly, to create a novel, gold-standard gene-editing technology, supporting innovation throughout the global biotechnology industry.

Aonghus Topham

May 29, 2024